Crossmark

ASO Author Reflections: Trajectory of Treatment-Related Adverse Events During Neoadjuvant Immunochemotherapy in Esophageal Cancer: A Further Step Toward Personalized Medicine

Crossref DOI link: https://doi.org/10.1245/s10434-024-16867-5

Published Online: 2025-01-09

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zijie

Huang, Shujie

Chen, Rixin

Qiao, Guibin https://orcid.org/0000-0001-9200-9317
Funding

Funding for this research was provided by:

Guangzhou Major Clinical Technology Project (2023P-ZD05)

Natural Science Foundation of Guangdong Province (2022A1515012469, 2023A1515010507)

Guangzhou Science and Technology Plan Projects (202206010103)
License Information

Text and Data Mining valid from 2025-01-09

Version of Record valid from 2025-01-09
More Information

Article History

Received: 19 December 2024

Accepted: 26 December 2024

First Online: 9 January 2025

Disclosure

: The authors declare that they have no conflict of interest.

: The present study was approved by the Ethics Committee of Guangdong Provincial People’s Hospital (KY 2020-195H-2).

Document is current

Any future updates will be listed below